Paediatric lamotrigine use hit by rash reports.

Reports that clinical trial and postmarking data show that lamotrigine, an antiepileptic, is more likely to produce dangerous skin rashes in children than previously suspected. Letters from GlaxoWellcome, manufacturer of the lamotrigne, Lamictal, to physicians in the United Kingdom and the United States; The risk levels for use of Lamictal by children and adults; When most life-threatening reactions occur; Number of countries in which lamotrigine is approved.